Research ArticleALLERGY

Proof-of-concept clinical trial of etokimab shows a key role for IL-33 in atopic dermatitis pathogenesis

See allHide authors and affiliations

Science Translational Medicine  23 Oct 2019:
Vol. 11, Issue 515, eaax2945
DOI: 10.1126/scitranslmed.aax2945

Log in to view full text

Log in through your institution

Log in through your institution

Navigate This Article